Drug-Resistant Glioma: Treatment with Imatinib Mesylate and Chlorimipramine
Abstract
Glioblastoma (GBM) is the most common and malignant primary brain tumor. Despite recent advances in treatment regimens, the prognosis of patients remains poor. Although different combined therapies of surgery, radiation and chemotherapy are being essayed
URI
https://doi.org/10.1007/978-94-007-0344-5_26http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1767
Collections
DSpace@İYYU by Istanbul Yeni Yüzyil University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..
